Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].

Bain Capital Private Equity acquires controlling stake in Asia Pacific Medical Group

March 15, 2016

Media Contacts

Share this page

Bain Capital Private Equity acquires controlling stake in Asia Pacific Medical Group

HONG KONG, March 15, 2016 - Bain Capital Private Equity today announced the acquisition of a large majority stake in Asia Pacific Medical Group (“APMG” or the “Company”), a leading private hospital group in China, from existing shareholders.

Established in 1992, APMG provides a range of primary care and specialty services, with a focus on neurology and oncology. The company introduced the first Gamma Knife machine to China and has since built a portfolio of hospitals and clinics in China and other parts of Southeast Asia, while also partnering with leading hospitals in China to provide medical, research and technology services.

There is overwhelming demand in China’s healthcare sector, which is exerting a huge amount of pressure on the under-resourced state medical system. “As one of the leading private healthcare companies in China, APMG is able to provide patients with quicker and affordable access to professional treatment”, said Jonathan Zhu, a Managing Director of Bain Capital Private Equity.

“Bain Capital Private Equity’s long history of working with healthcare businesses and proven operational model will help enhance APMG’s leading position as a premium healthcare provider, particularly in the supply constrained neurology and oncology treatment market.”

With Bain Capital Private Equity’s operational expertise, APMG is well positioned to meet the growing demand for quality healthcare services in China. The firm also plans to inject further funding into to the business for new expansion projects in China’s tier I cities. Furthermore, Bain Capital Private Equity’s extensive global healthcare network will enable APMG to build greater connections with the international medical communities and institutions that will further advance its research capabilities and specialist expertise.

About Asia Pacific Medical Group

Asia Pacific Medical Group (APMG) is a leading medical services provider founded by Dr. Michael Choy and a group of US-based physicians and surgeons in 1992. It is one of the fastest growing international healthcare providers in Asia with 5 hospitals and a number of clinics in China and Southeast Asia. APMG’s hospitals and clinics offer a range of primary care and specialty services, including neurology, oncology, cardiovascular, paediatrics and dermatology. Through close collaboration with major hospitals and clinic chains in the region, the Group services local and international patients in China, Singapore, Malaysia and Hong Kong. APMG aims to provide patients with quick and easier access to quality healthcare services.

About Bain Capital Private Equity

Bain Capital Private Equity has partnered closely with management teams to provide the strategic resources that build great companies and help them thrive since our founding in 1984. Our team of more than 400 investment professionals creates value for our portfolio companies through our global platform and depth of expertise in key vertical industries including consumer/retail, financial and business services, healthcare, industrials, and technology, media and telecommunications. In addition to private equity, Bain Capital invests across asset classes including credit, public equity and venture capital, and leverages the firm’s shared platform to capture opportunities in strategic areas of focus.

This press release has been updated to reflect the new business unit name, "Bain Capital Private Equity," which was changed from "Bain Capital" or "Bain Capital, LP."